Thermo Fisher Scientific | TMO - Operating Profit


Thermo Fisher Scientific reported $2.18B in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Agilent USD 399M 46M Mar/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Danaher USD 1.13B 217M Jun/2026
Dentsply International USD 84M 52M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
General Electric Aerospace USD 2.32B 549M Mar/2026
Henry Schein USD 200M 18M Jun/2026
Illumina USD 260M 21M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Laboratory Of America USD 456.7M 46.6M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Olympus JPY 30.07B 3.2B Jun/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quest Diagnostics USD 459M 60M Jun/2026
Repligen USD 21.13M 1.15M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Veracyte USD 23.96M 4.88M Jun/2026
Waters USD -86M 234M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026